KURA logo

Kura Oncology, Inc. (KURA) EBITDA

Annual EBITDA:

-$192.35M-$27.39M(-16.61%)
December 31, 2024

Summary

  • As of today, KURA annual EBITDA is -$192.35 million, with the most recent change of -$27.39 million (-16.61%) on December 31, 2024.
  • During the last 3 years, KURA annual EBITDA has fallen by -$61.65 million (-47.17%).
  • KURA annual EBITDA is now -4790.97% below its all-time high of -$3.93 million, reached on December 31, 2014.

Performance

KURA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKURAincome statement metrics

Quarterly EBITDA:

-$79.83M-$7.39M(-10.20%)
September 30, 2025

Summary

  • As of today, KURA quarterly EBITDA is -$79.83 million, with the most recent change of -$7.39 million (-10.20%) on September 30, 2025.
  • Over the past year, KURA quarterly EBITDA has dropped by -$20.16 million (-33.78%).
  • KURA quarterly EBITDA is now -1604.01% below its all-time high of -$4.68 million, reached on March 31, 2015.

Performance

KURA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKURAincome statement metrics

TTM EBITDA:

-$238.99M-$20.16M(-9.21%)
September 30, 2025

Summary

  • As of today, KURA TTM EBITDA is -$238.99 million, with the most recent change of -$20.16 million (-9.21%) on September 30, 2025.
  • Over the past year, KURA TTM EBITDA has dropped by -$22.34 million (-10.31%).
  • KURA TTM EBITDA is now -5001.07% below its all-time high of -$4.68 million, reached on March 31, 2015.

Performance

KURA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKURAincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

KURA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-16.6%-33.8%-10.3%
3Y3 Years-47.2%-119.3%-74.4%
5Y5 Years-185.1%-231.0%-183.0%

KURA EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-47.2%at low-258.8%at low-74.4%at low
5Y5-Year-185.1%at low-258.8%at low-183.0%at low
All-TimeAll-Time-4791.0%at low-1604.0%at low-5001.1%at low

KURA EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
-$79.83M(-10.2%)
-$238.99M(-9.2%)
Jun 2025
-
-$72.44M(-12.4%)
-$218.83M(-8.0%)
Mar 2025
-
-$64.46M(-189.7%)
-$202.59M(-5.3%)
Dec 2024
-$192.35M(-16.6%)
-$22.25M(+62.7%)
-$192.35M(+11.2%)
Sep 2024
-
-$59.68M(-6.2%)
-$216.64M(-8.7%)
Jun 2024
-
-$56.20M(-3.7%)
-$199.22M(-9.0%)
Mar 2024
-
-$54.22M(-16.5%)
-$182.81M(-10.8%)
Dec 2023
-$164.96M(-18.6%)
-$46.55M(-10.2%)
-$164.96M(-7.6%)
Sep 2023
-
-$42.26M(-6.2%)
-$153.36M(-4.0%)
Jun 2023
-
-$39.79M(-9.4%)
-$147.50M(-3.2%)
Mar 2023
-
-$36.36M(-4.0%)
-$142.86M(-2.7%)
Dec 2022
-$139.11M(-6.4%)
-$34.95M(+4.0%)
-$139.11M(-1.5%)
Sep 2022
-
-$36.40M(-3.6%)
-$137.03M(-2.1%)
Jun 2022
-
-$35.15M(-7.8%)
-$134.14M(-1.2%)
Mar 2022
-
-$32.60M(+0.8%)
-$132.52M(-1.4%)
Dec 2021
-$130.70M(-42.5%)
-$32.87M(+1.9%)
-$130.70M(-5.4%)
Sep 2021
-
-$33.52M(+0.0%)
-$124.05M(-8.2%)
Jun 2021
-
-$33.52M(-8.9%)
-$114.66M(-12.1%)
Mar 2021
-
-$30.79M(-17.4%)
-$102.29M(-11.5%)
Dec 2020
-$91.70M
-$26.22M(-8.7%)
-$91.70M(-8.6%)
Sep 2020
-
-$24.12M(-14.0%)
-$84.44M(-8.3%)
Jun 2020
-
-$21.16M(-4.8%)
-$78.00M(-7.2%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$20.20M(-6.5%)
-$72.73M(-7.8%)
Dec 2019
-$67.48M(-7.3%)
-$18.96M(-7.3%)
-$67.48M(-3.6%)
Sep 2019
-
-$17.67M(-11.2%)
-$65.15M(-2.7%)
Jun 2019
-
-$15.89M(-6.3%)
-$63.46M(-1.0%)
Mar 2019
-
-$14.95M(+10.1%)
-$62.84M(+0.1%)
Dec 2018
-$62.87M(-74.4%)
-$16.63M(-4.1%)
-$62.87M(-9.9%)
Sep 2018
-
-$15.98M(-4.6%)
-$57.23M(-12.8%)
Jun 2018
-
-$15.27M(-1.9%)
-$50.74M(-16.9%)
Mar 2018
-
-$14.99M(-36.4%)
-$43.39M(-20.4%)
Dec 2017
-$36.05M(-27.2%)
-$10.99M(-15.8%)
-$36.05M(-10.8%)
Sep 2017
-
-$9.49M(-19.8%)
-$32.53M(-8.1%)
Jun 2017
-
-$7.92M(-3.6%)
-$30.09M(-3.9%)
Mar 2017
-
-$7.64M(-2.3%)
-$28.95M(-2.2%)
Dec 2016
-$28.34M(-20.2%)
-$7.47M(-6.0%)
-$28.34M(-2.3%)
Sep 2016
-
-$7.05M(-3.9%)
-$27.70M(-2.2%)
Jun 2016
-
-$6.78M(+3.5%)
-$27.11M(-4.2%)
Mar 2016
-
-$7.03M(-2.9%)
-$26.02M(-9.9%)
Dec 2015
-$23.58M(-499.5%)
-$6.83M(-5.8%)
-$23.67M(-40.6%)
Sep 2015
-
-$6.46M(-13.5%)
-$16.84M(-62.2%)
Jun 2015
-
-$5.69M(-21.5%)
-$10.38M(-121.5%)
Mar 2015
-
-$4.68M
-$4.68M
Dec 2014
-$3.93M
-
-

FAQ

  • What is Kura Oncology, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Kura Oncology, Inc.?
  • What is Kura Oncology, Inc. annual EBITDA year-on-year change?
  • What is Kura Oncology, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Kura Oncology, Inc.?
  • What is Kura Oncology, Inc. quarterly EBITDA year-on-year change?
  • What is Kura Oncology, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Kura Oncology, Inc.?
  • What is Kura Oncology, Inc. TTM EBITDA year-on-year change?

What is Kura Oncology, Inc. annual EBITDA?

The current annual EBITDA of KURA is -$192.35M

What is the all-time high annual EBITDA for Kura Oncology, Inc.?

Kura Oncology, Inc. all-time high annual EBITDA is -$3.93M

What is Kura Oncology, Inc. annual EBITDA year-on-year change?

Over the past year, KURA annual EBITDA has changed by -$27.39M (-16.61%)

What is Kura Oncology, Inc. quarterly EBITDA?

The current quarterly EBITDA of KURA is -$79.83M

What is the all-time high quarterly EBITDA for Kura Oncology, Inc.?

Kura Oncology, Inc. all-time high quarterly EBITDA is -$4.68M

What is Kura Oncology, Inc. quarterly EBITDA year-on-year change?

Over the past year, KURA quarterly EBITDA has changed by -$20.16M (-33.78%)

What is Kura Oncology, Inc. TTM EBITDA?

The current TTM EBITDA of KURA is -$238.99M

What is the all-time high TTM EBITDA for Kura Oncology, Inc.?

Kura Oncology, Inc. all-time high TTM EBITDA is -$4.68M

What is Kura Oncology, Inc. TTM EBITDA year-on-year change?

Over the past year, KURA TTM EBITDA has changed by -$22.34M (-10.31%)
On this page